Posted in | News | Coal | Mining Business

Morien Resources Provides Update on Production and Development Activities at Donkin Coal Mine

Morien Resources Corp., is pleased to provide an update on production and development activities at the Donkin Coal Mine in Cape Breton, Nova Scotia.

Owner/operator Kameron Collieries ULC (“Kameron”), an affiliate of the Cline Group LLC, recently provided Morien executives with a site tour of the mining operation. A series of recent photos of the operation can be viewed on Morien’s website by clicking here, and an update on Donkin is provided below. Morien has a gross production royalty of 2% to 4% on all coal sales from Donkin.

Donkin Coal Mine Highlights

• Current production is from a single continuous miner unit, with the addition of a second continuous miner unit expected before the end of Q3 2017;
• It is anticipated that four continuous miner units will be operational in 2018;
• Kameron is anticipating production of approximately 350,000 to 450,000 tonnes in 2017, 1.2 to 1.8 million tonnes in 2018, and 2.6 to 2.75 million tonnes of salable coal in 2019
(production volumes are subject to change based on numerous market and non-market factors);
• A coal handling, preparation and processing plant (“washplant”) is nearly complete, and is expected to become operational before the end of Q3 2017;
• The washplant has been designed to process 500 tonnes per hour (“tph”), enough to process the permitted production at Donkin;
• Current coal production is being trucked and stockpiled at the Provincial Energy Ventures port in Sydney, Cape Breton;
• A total of 64 full-time employees/contractors are currently working onsite at Donkin, and Kameron is forecasting a total of 135 full-time workers onsite at full production;
* The Donkin Coal Technical Report, dated November 2012, found on Morien’s SEDAR profile, supports the above technical disclosures.

Morien Royalty and Milestone Payments

On February 27, 2015, Morien sold its 25% working interest in Donkin to Kameron for aggregate cash consideration of $5.5 million and a gross production royalty.

Morien owns a gross production royalty of 2% on the first 500,000 tonnes of coal sales per calendar quarter (excluding the initial 10,000 tonnes of coal produced and sold from Donkin) and 4% on any coal sales from quarterly tonnage above 500,000 tonnes (“Royalty”). The Royalty is payable to Morien on a quarterly basis over the anticipated 30 plus year mine life.

Using a range of coal pricing, annual royalty payments could be in the order of $4.0 million to $8.0 million at full production. These values are only estimates based on Q2 2017 assumptions that Morien management consider to be reasonable. Actual results and royalties received, if any, and subject primarily to production rates and coal pricing, may vary from those estimated by Morien.

Morien received a $2 million milestone payment on closing of the transaction with Kameron (February 27, 2015) and received a second milestone payment of $2 million on the second anniversary of the closing (February 27, 2017; click here for Morien news release). Morien is entitled to receive an additional $1.5 million milestone payment on the earlier of first commercial sale of export coal from Donkin and the third anniversary of the closing of the transaction (February 27, 2018).

Qualified Person

Dawson Brisco, P.Geo. (Nova Scotia), Vice President Corporate Development, is a Qualified Person as that term is defined in National Instrument 43-101 and has reviewed and approved the scientific and technical information contained in this news release.

Source: http://morienres.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.